PARP14, overexpressed in multiple myeloma, functions as a transcriptional co-activator for STAT6, facilitating the Th2 immune response, promoting metabolic changes to an anaerobic state, and activating cell survival pathways through JNK2 and the PGI/AMF complex [183]. Here, PARP14 is linked to plasma cell myeloma.